Mycobacterium brisbanense

Jump to navigation Jump to search
Mycobacterium brisbanense
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. brisbanense
Binomial name
Mycobacterium brisbanense
Schinsky et al. 2004, ATCC 49938

WikiDoc Resources for Mycobacterium brisbanense

Articles

Most recent articles on Mycobacterium brisbanense

Most cited articles on Mycobacterium brisbanense

Review articles on Mycobacterium brisbanense

Articles on Mycobacterium brisbanense in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mycobacterium brisbanense

Images of Mycobacterium brisbanense

Photos of Mycobacterium brisbanense

Podcasts & MP3s on Mycobacterium brisbanense

Videos on Mycobacterium brisbanense

Evidence Based Medicine

Cochrane Collaboration on Mycobacterium brisbanense

Bandolier on Mycobacterium brisbanense

TRIP on Mycobacterium brisbanense

Clinical Trials

Ongoing Trials on Mycobacterium brisbanense at Clinical Trials.gov

Trial results on Mycobacterium brisbanense

Clinical Trials on Mycobacterium brisbanense at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mycobacterium brisbanense

NICE Guidance on Mycobacterium brisbanense

NHS PRODIGY Guidance

FDA on Mycobacterium brisbanense

CDC on Mycobacterium brisbanense

Books

Books on Mycobacterium brisbanense

News

Mycobacterium brisbanense in the news

Be alerted to news on Mycobacterium brisbanense

News trends on Mycobacterium brisbanense

Commentary

Blogs on Mycobacterium brisbanense

Definitions

Definitions of Mycobacterium brisbanense

Patient Resources / Community

Patient resources on Mycobacterium brisbanense

Discussion groups on Mycobacterium brisbanense

Patient Handouts on Mycobacterium brisbanense

Directions to Hospitals Treating Mycobacterium brisbanense

Risk calculators and risk factors for Mycobacterium brisbanense

Healthcare Provider Resources

Symptoms of Mycobacterium brisbanense

Causes & Risk Factors for Mycobacterium brisbanense

Diagnostic studies for Mycobacterium brisbanense

Treatment of Mycobacterium brisbanense

Continuing Medical Education (CME)

CME Programs on Mycobacterium brisbanense

International

Mycobacterium brisbanense en Espanol

Mycobacterium brisbanense en Francais

Business

Mycobacterium brisbanense in the Marketplace

Patents on Mycobacterium brisbanense

Experimental / Informatics

List of terms related to Mycobacterium brisbanense

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mycobacterium brisbanense is a member of the Mycobacterium fortuitum third biovariant complex. They are rapidly growing ubiquitous environmental organisms that normally inhabit soil, dust and water. These organisms frequently are human pathogens that cause a wide spectrum of clinically significant disease. It is important for practitioners to be aware of these organisms as possible etiological agents, as they are resistant to most first-line anti-tuberculous agents.

  • Etymology: brisbanense, pertaining to Brisbane, Queensland, Australia, the source of the type strain.


Description

Microscopy

  • The organisms are acid-fast, Gram-positive, pleomorphic bacilli. Long filamentous forms are often observed, but spores and capsules are absent.

Colony characteristics

  • Colonies are mucoid, convex, round, entire-edged and do not demonstrate aerial hyphae.
  • Colonies are white to slightly beige and small in diameter (approx. 1 mm) after incubation on heart infusion agar with 5 % (v/v) rabbit blood for 2 days at 35 °C.

Physiology

  • Growth occurs on Löwenstein–Jensen medium at 35 °C in less than 7 days, but no growth occurs at 42 °C.
  • Growth occurs on 5 % NaCl and on MacConkey's agar without crystal violet at 28 °C.
  • Arylsulfatase activity by 3 days, utilizes acetamide, reduces nitrate, produces urease and exhibits iron uptake.
  • It does not utilize citrate or grow in lysozyme. Semi-quantitative catalase activity is weakly positive (<45 mm).
  • It does not utilize citrate, grow in lysozyme or produce thermostable catalase.

Differential characteristics

  • The nearest phylogenetic neighbour, according to 16S rRNA gene sequence similarity, is Mycobacterium diernhoferi ATCC 19340T.

Pathogenesis

  • Reported infections include skin and soft-tissue abscesses with associated osteomyelitis, bacteraemia, endocarditis, keratitis, lymphadenitis, peritonitis, post-surgical infections, pulmonary infections and disseminated disease. Involvement of the central nervous system is rare, but meningitis may develop after trauma or surgery. The immunocompromised patient is at special risk for developing severe diseases, especially catheter-related infection with bacteraemia.


Type Strain

  • First isolated from an antral sinus in Brisbane, Queensland, Australia
  • Strain W6743 = ATCC 49938 = CCUG 47584 = DSM 44680


References

  • Schinsky M.F., 2004. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int. J. Syst. Evol. Microbiol., 2004, 54, 1653-1667.


de:Mycobacterium brisbanense nl:Mycobacterium brisbanense

Template:SIB


Template:WikiDoc Sources